Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome
Authors
Keywords
-
Journal
Clinical and Experimental Nephrology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-18
DOI
10.1007/s10157-020-01970-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LC-MS/MS method for simultaneous quantification of heparan sulfate and dermatan sulfate in urine by butanolysis derivatization
- (2018) Giulia Forni et al. CLINICA CHIMICA ACTA
- Sphingomyelinase-like phosphodiesterase 3b mediates radiation-induced damage of renal podocytes
- (2017) Anis Ahmad et al. FASEB JOURNAL
- Urinary excretion of sphingomyelinase phosphodiesterase acid-like 3b in children with intractable nephrotic syndrome
- (2017) Shojiro Watanabe et al. PEDIATRICS INTERNATIONAL
- Rituximab for nephrotic syndrome in children
- (2016) Kazumoto Iijima et al. Clinical and Experimental Nephrology
- LC–MS/MS as a tool for TDM services: Where are we?
- (2016) Maria Shipkova et al. CLINICAL BIOCHEMISTRY
- Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes
- (2016) Yuichi Takahashi et al. NEPHROLOGY
- Toll-like Receptor 9 Can be Activated by Endogenous Mitochondrial DNA to Induce Podocyte Apoptosis
- (2016) Wenduona Bao et al. Scientific Reports
- The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity
- (2015) Leonhard X. Heinz et al. Cell Reports
- Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1 in human mesangial cells
- (2014) Tadaatsu Imaizumi et al. Clinical and Experimental Nephrology
- Detection of urinary podocytes and nephrin as markers for children with glomerular diseases
- (2014) Pei Wang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Sphingomyelinase-Like Phosphodiesterase 3b Expression Levels Determine Podocyte Injury Phenotypes in Glomerular Disease
- (2014) T.-H. Yoo et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
- (2014) Kazumoto Iijima et al. LANCET
- Podocyte Pathology and Nephropathy – Sphingolipids in Glomerular Diseases
- (2014) Sandra Merscher et al. Frontiers in Endocrinology
- Glomerular expression of myxovirus resistance protein 1 in human mesangial cells: Possible activation of innate immunity in the pathogenesis of lupus nephritis
- (2013) Shojiro Watanabe et al. NEPHROLOGY
- Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome
- (2012) Shuichi Ito et al. PEDIATRIC NEPHROLOGY
- LPS and PAN-induced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile
- (2012) Tarak Srivastava et al. Journal of Cell Communication and Signaling
- Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis
- (2011) A. Fornoni et al. Science Translational Medicine
- Liquid chromatography-tandem mass spectrometry applications in endocrinology
- (2009) Mark M. Kushnir et al. MASS SPECTROMETRY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search